Protego Biopharma Funding: $181M Raised, Series B (2025)
Protego Biopharma is a Biotech company based in Sherborn, Massachusetts. It has raised $181M in total funding. Latest round: Series B.
Protego Biopharma funding overview
Protego Biopharma is a Biotech company based in Sherborn, Massachusetts. Protego Biopharma has raised $181M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2025. The round record for Protego Biopharma runs through 2025; nothing later has been disclosed. Investors on record include Novartis Venture Fund, Forbion, Omega Funds, Droia Ventures, YK Bioventures, Digitalis Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Protego Biopharma has raised $181M in total disclosed funding across the rounds on record.
Who has invested in Protego Biopharma?
Novartis Venture Fund, Forbion, Omega Funds, Droia Ventures, YK Bioventures, Digitalis Ventures are named among the investors backing Protego Biopharma.
What was the latest Protego Biopharma funding round?
The most recent disclosed round is a Series B, announced in December 2025.
Where is Protego Biopharma based?
Protego Biopharma is based in Sherborn, Massachusetts.
What sector does Protego Biopharma operate in?
Protego Biopharma is tracked under Biotech from Sherborn, Massachusetts, with $181M in disclosed funding.
When did Protego Biopharma last raise?
The last disclosed Protego Biopharma round closed in December 2025 at Series B.
We update the Protego Biopharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Sherborn and their backers are listed below.
